Rhythm Pharmaceuticals, Inc. (RYTM)
87.45
-2.86
(-3.17%)
USD |
NASDAQ |
Mar 20, 16:00
88.00
+0.55
(+0.63%)
After-Hours: 20:00
Rhythm Pharmaceuticals Research and Development Expense (Quarterly) : 42.03M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 4.304M |
| Merck & Co., Inc. | 2.499B |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| MannKind Corp. | 27.59M |
| EyePoint Plc | 59.21M |